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The value of exercise testing and thallium scintig- 
raphy in predicting recurrence of angina pectoris and 
restenosis after a primary successful transluminal 
coronary angioplasty (PTCA) was prospectively 
evaluated. In 89 patients, a svmptom-limited exer- 
cise electrocardiogram (EC.;) and thallium scin- 
tigraphy were performed 4 weeks after they had 
undergone successful PTCA. Thereafter, the patients 
were followed for 6.4 f 2.5 months (mean f. stan- 
dard deviation) or until recurrence of angina. They 
all underwent a repeat coronary angiography at 6 
months or earlier if symptoms recurred. PTCA was 
considered successful if the patients had no symp- 
toms and if the stenosis was reduced to less than 
50% of the luminal diameter. Restenosis was de- 
fined as an increase of the stenosis to more than 
50% luminal diameter. The ability of the thallium 
scintigram (presence of a reversible defect) to 
predict recurrence of angina was 66 %, vs 38 % for 
the exercise ECG (ST-segment depression or angina 
at peak workload). Restenosis was predicted in 
74% of patients by thallium scintigraphy, but only 
in 50% of patients by the exercise ECG. Thus, 
thallium scintigraphy was highly predictive but the 
exercise ECG was not (p <O-005). These results 
suggest that restenosis had occurred to some extent 
already at 4 weeks after the PTCA in most patients 
in whom it was going to occur. 
(Am J Cardiol 1985;55:357-361) 
Restenosis after primary successful percutaneous 
transluminal coronary angioplasty (PTCA) occurs in 
19 to 36% of patients within the first 6 months after the 
procedure.1-5 This restenosis may manifest itself by 
changes in the patient’s clinical status and may be de- 
tected by noninvasive diagnostic tests or by coronary 
angiography. Scholl2 and Hirze16 and their co-workers 
showed that an abnormal response on the exercise 
electrocardiogram (ECG) and a myocardial perfusion 
defect on the thallium scintigram is associated with 
angiographically documented restenosis of the dilated 
vessel or is a sign of the presence of additional disease. 
The present study was performed to determine the 
value of early noninvasive testing in the prediction of 
restenosis and recurrence of symptoms. The study pa- 
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tients had undergone technically successful PTCA, 
which resulted in a “complete” anatomic correction. 
They were all free of angina pectoris up to the time of 
exercise electrocardiography and thallium scintigraphy, 
which were performed a median of 4 weeks after PTCA. 
Follow-up data regarding subsequent recurrence of 
symptoms and repeat coronary angiography a median 
of 6 months after the procedure were compared in a 
prospective manner with the noninvasive test results 
obtained at 4 weeks. 
Methods 
Between September 1980 and September 1983, 296 con- 
secutive first PTCA procedures for stable or unstable angina 
pectoris were attempted at the Thoraxcenter; 221 were pri- 
mary successes. The 162 patients from our own institution 
were asked to cooperate with a follow-up protocol, which in- 
cluded an exercise electrocardiogram and thallium scintigram 
4 to 6 weeks after the procedure, a visit to the outpatient clinic 
at 2-month intervals and a repeat angiogram at 6 to 8 months. 
The 59 patients referred from institutions in other cities were 
excluded. One hundred twenty patients met the inclusion 
criteria for the present study: “complete” anatomic correction, 
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TABLE I Characteristics of the Angioplasty Procedure 
Group 2 
Group 1 Long-Term 
Restenosis” Success 
(rl = 35) (n = 54) 
Dilated LAD 25 34 
vessel LCX 6 3 
(n = 93) RCA 5 19 
Bypass 1 0 
% diameter Pre 66f 15 NS 62f 11 
stenosis Post 33f 12 NS 31 f 13 
Late 62 f 14 31 f 13 
Pressure Before 0.64 f 0.16 (33) NS 0.61 f 0.13 (55) 
gradient After 0.19 Jt 0.11 (35) NS 0.16 f 0.10 (55) 
The translesional pressure gradient is normalized for the mean aortic 
pressure; numbers under parentheses refer to the number of available 
measurements. * Stenosis more than 50 % in luminal diameter at repeat 
angiography. 
LAD = left anterior descending coronary artery; LCX = left circumflex 
coronary artery; NS = not significant; RCA = right coronary artery. 
i.e., no significant residual coronary obstructions after PTCA, 
absence of angina until the time of exercise testing; and ability 
to complete the exercise test. Thirty-one patients refused to 
undergo repeat coronary angiography. This report is thus 
based on the prospective evaluations of 89 patients, 74 men 
and 15 women. A single stenosis was dilated in 85 patients and 
2 stenoses were dilated in 4 patients. The dilated vessel was 
the left anterior descending artery in 59 patients, the left 
circumflex in 9, the right coronary artery in 24 and the distal 
anastomotic site of a saphenous vein bypass graft on the left 
anterior descending coronary artery in 1 patient. PTCA was 
performed according to the technique of Gruentzig,l with 
Schneider equipment through a femoral route. Details re- 
garding the procedure used in our laboratory were described 
previously.7T8 he PTCA procedure was considered successful 
when the residual stenosis was less than 50% in diameter with 
a good run off and filling of the distal vessel at angiography. 
In the 91 stenoses with satisfactory recordings, the residual 
pressure gradient (normalized for the mean aortic pressure) 
was less than 0.20 in 63 cases and less than 0.40 in 25 cases. 
In an attempt to reduce the restenosis rate,3*5 all patients 
received nifedipine, 10 mg every 2 hours for the first 8 hours 
after the procedure and received maintenance therapy on 
salicylic acid, 500 mg/day, and nifedipine, 10 mg 3 to 6 times 
daily, until repeat angiography was performed. Beta-blocking 
agents were stopped unless the patient had hypertension. 
Repeat angiography was performed 7.0 f 2.3 months (mean 
f standard deviation) after PTCA in the patients who re- 
mained asymptomatic and 4.9 f 2.3 months after PTCA in 
patients who had recurrent angina during follow-up. Coronary 
angiography was performed in multiple views (including 
hemiaxial views for the left coronary artery) and were inter- 
preted visually without knowledge of the initial noninvasive 
test results. The clinical definition of restenosis was an in- 
crease of the diameter stenosis of the dilated lesion above the 
50% level. In addition, quantitative analysis of the dilated 
stenosis was obtained in the same angiographic projection for 
each angiogram by means of our computer-based coronary 
angiographic analysis system. g Based on these accurate and 
more objective measurements of stenosis severity,10 the def- 
inition of restenosis used by the National Heart, Lung, and 
Blood Institute (NHLBI) registry4 was applied as well, i.e., 
an increase in stenosis of at least 30% frcm the immediate 
post-PTCA result or the loss of at least half the initial gain in 
diameter. 
The exercise studies were performed 4.7 f 1.9 weeks after 
PTCA. The subjects performed a symptom-limited exercise 
TABLE II Exercise Test Results and Recurrence of 
Symptoms During Follow-Up 
Group 1 
Restenosis 
(n = 35) 
Group 2 
Long-Term 
Success 
(n = 54) 
Weeks after PTCA 4.7 f 2.3 (2-l 1) NS 4.7 f 1.7 (2-8) 
@wa4 
Maximal workload 
(% of predicted) 
Maximal heart rate 
Abnormal exercise 
ECG 
Angina during test 
ST deoression 
96f 13 NS 90f 16 
140 f 28 NS 149f22 
13 
1: 
13 
1: 
Xii mV 
Both 
Abnormal 
scintigram 
Recurrent angina 
New myocardial 
infarction 
2; 9” 
23 
0 : 
ECG = electrocardiogram; NS = not significant; PTCA = percuta- 
neous transluminal coronary angioplasty. 
test on the bicycle ergometer with stepwise increments of 20 
W/min. The 3 orthogonal eads XYZ of the Frank lead system 
were recorded and analyzed as previously described.rl The 
reported sensitivity and specificity for the diagnosis of sig- 
nificant coronary disease were 85% and 90%, respectively. 
Horizontal ST depression of 0.1 mV or greater and typical 
angina during exercise were considered as abnormal (or pos- 
itive) responses. One minute before peak exercise, thallium, 
1.5 mCi, was injected intravenously. Imaging was started 5 
minutes later in 3 views: anterior, left anterior oblique 45O and 
65’. Static planar images (500 kcounts full field, zoom 2 X) 
were obtained after exercise and 4 hours later with a Searle 
Phogamma V camera. The scintigraphic images were pro- 
cessed on a DEC gamma-11 system with a quantification 
procedure developed at our institution.12 The late image was 
corrected for acquisition time differences with respect to the 
early image. The exercise and redistribution images were 
registered on the basis of the detected positions of point 
sources taped to the patient’s chest. After automated left 
ventricular contour detection’s and interpolative background 
correction,14 circumferential profiles were computed at 6” 
intervals. The profiles of the early and late images were nor- 
malized for the maximal value in the early image (100%) ex- 
cluding the outflow tract of the left ventricle. The analog 
Polaroid@ images from the gamma camera, the processed 
images and the circumferential profiles were analyzed pro- 
spectively on a routine basis by 3 experienced observers 
without knowledge of the angiographic data. The thallium 
uptake in a total of 11 segments was scored both in the post- 
exercise and late images on a 5-point scale: 0 = no thallium 
uptake; 1 = severely abnormal; 2 = definitely abnormal; 3 = 
doubtfully abnormal; and 4 = normal. The following segments 
were defined: posteroseptal, inferior, apical and anterolateral 
in the anterior view; anteroseptal, apical and posterolateral 
in the left anterior oblique 45’ view; and anterior, apical, in- 
ferior and posterior in the left anterior oblique 65’ view. The 
scores of all segments were summed per patient and the dif- 
ference between late and early postexercise sums was taken 
as a measure of the amount of redistribution. An increase in 
thallium uptake score of 2 points or more between postexercise 
and late images was taken as the cutoff between normal (ab- 
sence of exercise-induced ischemia) and abnormal (presence 
of exercise induced ischemia) scintigrams. Persistent defects 
without redistribution were considered to represent scars 
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TABLE III Positive and Negative Predictive Values of the Noninvasive Tests 
Restenosis 
50 % Diameter 
Present Absent 
(n = 35) (n = 54) 
NHLBI Criteria* 
Present Absent 
(n = 37) (n = 52) 
Recurrent Angina 
Present Absent 
(n = 29) (n = 60) 
Predictive value 
Exercise ECG 
ST seament 
+ - + - 
55 66 55 63 
+ 
32 67 
ST and/or AP 
Thallium 
ww (446:67) uy (42Q367) (73/82) (45:067) 
U3/‘7 (4 ‘8/363) U4:426) (408/063) (7”6) (448/93) 
scintigraphy (26135) (45154) (26/35) (43154) (23135) (48154) 
Positive (+) and negative (-) predictive values of respectively abnormal and normal tests are per- 
centages. 
l An increase in stenosis of 30% or more from the immediate post-PTCA result and/or the loss of at 
least half the initial gain in diameter. 
AP = angina pectoris; ECG = electrocardiogram; NHLBI = National Heart, Lung, and Blood Institute. 
without exercise-induced ischemia. With this analysis, the 
previously reported sensitivity and specificity for the diagnosis 
of significant coronary artery obstructions were 80 and 88%, 
respectively.12 The patients were followed up in the outpatient 
clinic until occurrence of typical angina pectoris or a new 
myocardial infarction. The follow-up duration was 6.4 f 2.5 
months. No patient died during this period. 
Results are presented as mean f standard deviation. The 
t test for paired or unpaired data was used whenever appro- 
priate. The positive predictive value for restenosis (or recur- 
rent angina) was calculated as the frequency of restenosis (or 
recurrent angina) in those with abnormal test results. The 
negative predictive value for the absence of restenosis (or re- 
current angina) was calculated as the frequency of long-term 
success in those with normal test results. Differences between 
correct and incorrect classifications by exercise ECG vs 
thallium were evaluated by the McNemar test. 
Results 
The characteristics of the PTCA procedure are listed 
in Table I for 2 groups: patients with restenosis of the 
dilated vessel, i.e., diameter stenosis at repeat angiog- 
raphy more than 50% (n = 35), and patients with long- 
term success (n = 54). There was no significant differ- 
ence between these 2 groups in the pressure gradient 
across the stenosis either before or after PTCA. The 
exercise test results and the recurrence of symptoms 
during the follow-up are summarized for both groups 
in Table II. The mean timing of exercise testing after 
PTCA and the resultant maximal workloads and heart 
rates achieved were similar for both groups. Ninety-two 
percent of the patients reached 80% of their predicted 
maximal workload. An abnormal exercise ECG was 
observed in 26 patients: 21 had ST-segment depression, 
4 had angina at peak workload and 1 patient had both. 
Exercise-induced ischemia as assessed by the thalli- 
um redistribution was observed in 35 patients. During 
the follow-up, angina recurred in 29 patients. No patient 
had a new myocardial infarction in the territory of the 
dilated vessel. The positive and negative predictive 
values of each single test are shown in Table III. Thal- 
lium was superior to the exercise ECG both for the 
prediction of recurrent stenosis and recurrent angina 
(both p <0.005). The predictive value for recurrent 
stenosis of the 4 combinations of test results is shown 
in Figure 1. An abnormal scintigraphic response was 
associated with a high incidence of restenosis, which was 
not influenced by the result of the exercise ECG: 71% 
of restenoses when both tests were abnormal vs 76% 
when tests were discordant. Conversely, a normal 
scintigraphic response was associated with a low inci- 
dence of restenosis, which was also not influenced by the 
result of the exercise ECG: 14% of restenosis when 
both tests were normal and 25% when tests were 
discordant. 
The value of combined noninvasive test results for the 
prediction of recurrent angina is shown in Figure 2. 
Angina recurred in 64% of patients with both tests ab- 
normal and in 67% of patients with only thallium ab- 
normal. In the presence of a normal scintigraphic re- 
sponse, the recurrent angina was about lo%, regardless 
of the result of the response on the exercise ECG. 
% RESTENOSIS 
THALLIUM 
EX TEST 
76 
25 
q 14 cl 
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FIGURE 1. The predictive value for angiographic restenosis for the 
possible combinations of noninvasive test results: (+) = abnormal test 
and (-) = normal test; EX TEST = exercise electrocardiogram. Shaded 
columns represent the patients with abnormal scintigraphic responses. 
Both test results were abnormal in 14 and normal in 42 patients; only 
thallium was abnormal in 21 and only exercise ECG in 12 patients. 
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By the NHLBI definition of restenosis based on the 
quantitative analysis of the angiograms, only 6 patients 
were categorized in another group; 37 had restenosis by 
these criteria. The predictive value of the noninvasive 
tests was not significantly different: 54% restenosis 
when the exercise ECG was abnormal vs 74% restenosis 
when the scintigram was abnormal (Table III). 
Discussion 
The present report demonstrates that early assess- 
ment of myocardial perfusion by exercise thallium 
scintigraphy has a high predictive value for restenosis 
and recurrence of angina in patients who underwent a 
technically satisfactory PTCA. Previous studies216J5-I7 
assessing the results of PTCA by noninvasive tests have 
focused on the reversibility of the ischemic changes after 
a successful procedure and on their induction at the 
time of recurrence. However, more recently, DePuey et 
all8 reported that failure to increase ejection fraction 
or the development of a new regional wall motion ab- 
normality during exercise radionuclide ventriculog- 
raphy early after PTCA predicted restenosis at 4 to 12 
months in 73% of 41 patients. Their findings and those 
of the present study suggest that restenosis had oc- 
curred to some extent already at 4 weeks in most pa- 
tients in whom it was documented later. This observa- 
tion raises speculations about the underlying 
mechanism of restenosis after dilatation. Fibrocellular 
proliferations as a reparative response to coronary wall 
laceration has been described in necropsy studies19 and 
may represent the pathologic substrate of early reste- 
nosis. In analogy with aortic dissection, exposure of 
vascular smooth muscle cells to blood may trigger an 
exuberant tissue reaction, leading to obliteration of the 
false channel and eventually of the functional lumen. 
Preliminary data20 from experimental angioplasty in 
pigs suggest hat balloon dilatation is a potent stimulus 
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FIGURE 2. The predictive value of the noninvasive tests for the clinical 
endpoint (recurrent angina); other abbreviations as in Figure 1. 
to early platelet deposition and subsequent intimal 
hyperplasia. In this model, the reparative process was 
observed as early as 2 weeks after the procedure. If 
present in patients, such ongoing processes may have 
induced the observed perfusion abnormalities. Since 
only successful cases were included and the decrease in 
stenosis severity and in the transstenotic pressure gra- 
dient were comparable in patients with restenosis and 
long-term success, there is no evidence that recurrence 
occurred predominantly in patients in whom the dila- 
tation was incomplete. In this study, the high predictive 
value of the perfusion scintigram contrasts with the poor 
predictive value of the exercise electrocardiographic 
response, especially for the prediction of restenosis. 
This could be explained by a lower sensitivity of the 
exercise ECG compared with thallium scintigraphy in 
the detection of moderate coronary artery narrowing. 
The combination of a normal exercise ECG with a re- 
versible thallium perfusion abnormality could be an 
early indicator of the presence of a noncritical stenosis, 
still insufficient to induce ST-segment depression 
during exercise. 21 Indeed, 66% of the patients with an 
initially abnormal scintigram became symptomatic at 
a later stage during the follow-up period. 
The problem of defining restenosis is not trivial. 
Applying the stringent criteria of the NHLBI registry 
to visual estimations of stenosis severity has major 
limitations, due to the large intra- and interobserver 
differences in interpretation, especially for stenoses 
between 20 and 8O%.22 Therefore, the stenoses were 
analyzed by computerized edge detection. Although this 
method may not be optimal after angioplasty,g it pro- 
vides an objective and quantitative measurement, 
avoiding unintentional bias in reading the angiograms. 
This complex definition of restenosis resulted however 
in similar findings as the usual clinical approach based 
in the presence or the absence of a hemodynamically 
significant stenosis (X0% luminal diameter). By this 
clinical definition, restenosis of the dilated artery was 
observed in 39% and recurrent angina pectoris in 33% 
of the patients. 
The true incidence of recurrence is probably lower 
because most of the patients who refused to undergo 
repeat angiography were asymptomatic. The patient 
population is thus biased in favor of those with recur- 
rent stenosis. The clinical implication of these findings 
for the routine management of patients who undergo 
PTCA remains to be established. Certainly we share 
with DePuey et alI8 the conclusion that an abnormal 
noninvasive test early after PTCA in an asymptomatic 
patient is an indication for close clinical monitoring in 
view of the high chance of recurrence of symptoms. We 
believe that decisions to perform repeat angiography, 
followed by a redilatation when restenosis is found, 
should primarily be based on the severity of angina 
rather than on the results of the testing procedure. This 
is analogous to the issue of bypass surgery for docu- 
mented coronary artery disease in asymptomatic pa- 
tients, particularly since no benefit of surgical inter- 
vention over pharmacologic treatment was shown in 
mildly or nonsymptomatic patients.23 Until the outcome 
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of prophylactic PTCA is studied, the procedural com- 
plications and incomplete success rates militate against 
performing PTCA when diagnostic testing reveals re- 
stenosis in the absence of symfitoms. 
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